Security record · archived quarter
JAZZ
Jazz Pharmaceuticals plc · Healthcare · Biotechnology
15Tracked holders
0Δ holders
8.56MShares held
$1.05BReported value
+1New positions
−1Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -8.5% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 137 | +4 | 47.53M | $11.43B | +7 | −2 |
| Q1 2026 | 135 | -10 | 49.63M | $8.67B | +4 | −14 |
| Q4 2025 | 144 | +2 | 48.56M | $7.62B | +2 | — |
| Q3 2025 | 20 | 0 | 25.68M | $3.38B | +1 | −1 |
| Q2 2025 | 17 | -1 | 21.49M | $2.28B | +1 | −2 |
| Q1 2025 | 15 | 0 | 8.34M | $1.04B | +1 | −1 |
| Q4 2024 | 15 | 0 | 8.56M | $1.05B | +1 | −1 |
| Q3 2024 | 14 | -2 | 7.38M | $822.21M | — | −2 |
| Q2 2024 | 16 | — | 7.74M | $826.28M | — | — |
Who holds it · Q4 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 1.97M | — | $242.46M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (passive) | 1.97M | — | $242.46M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Capital World Investors ✦ | 1.92M | +5.7% | $236.86M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 1.09M | -1.9% | $134.70M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 1.09M | -1.9% | $134.70M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | Renaissance Technologies ✦ | 1.00M | -4.6% | $123.38M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 7 | Millennium Management ✦ | 611.29K | -6.2% | $75.28M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 8 | Millennium Management ✦ | 611.29K | -6.2% | $75.28M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 533.68K | -3.6% | $65.72M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 533.68K | -3.6% | $65.72M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 506.35K | -51.9% | $62.36M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 506.35K | -51.9% | $62.36M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 302.11K | +16.9% | $37.20M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | D. E. Shaw & Co. ✦ | 302.11K | +16.9% | $37.20M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | Bridgewater Associates ✦ | 192.03K | +69.9% | $23.65M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 187.13K | -41.5% | $23.04M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 17 | Two Sigma Investments ✦ | 187.13K | -41.5% | $23.04M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 18 | Point72 Asset Management ✦ | 84.15K | -68.7% | $10.36M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Point72 Asset Management ✦ | 84.15K | -68.7% | $10.36M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | Marshall Wace ✦ | 59.38K | New | $7.31M | 0.0% | New | 1 | SEC ↗ |
| 21 | Marshall Wace ✦ | 59.38K | New | $7.31M | 0.0% | New | 1 | SEC ↗ |
| 22 | Wellington Management ✦ | 41.80K | -6.8% | $5.15M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 23 | Wellington Management ✦ | 41.80K | -6.8% | $5.15M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 24 | Wellington Management ✦ | 41.80K | -6.8% | $5.15M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 25 | T. Rowe Price ✦ | 38.18K | +2.8% | $4.70M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 26 | Gotham Asset Management ✦ | 15.09K | -28.2% | $1.86M | 0.0% | ▼ Trim | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Marshall Wace | $7.31M | 0.0% |
| Marshall Wace | $7.31M | 0.0% |
Exited
| Arrowstreet Capital | $8.50M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 568 holders, 63.82M shares, $11.28B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q4 2024 ·
Methodology ·
Get this via the API